Physician profile
Lawrence W Freeman
NPI 1083606644
$2,071.75
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,874 · 2020: $181 · 2021: $16.94.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $505.93 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $287.99 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $206.64 | 2019 | |
| Gilead Sciences, INC. | $183.90 | 2019 | |
| Novartis Pharmaceuticals Corporation | $175.45 | 2019 | |
| Amarin Pharma, INC. | $124.06 | 2019-2020 | |
| Edwards Lifesciences Corporation | $111.09 | 2019 | |
| Lundbeck LLC | $104.82 | 2019 | |
| Hitachi Healthcare Americas Corp. | $66.59 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.43 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $51.47 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $45.06 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.77 | 2019-2020 | |
| Daiichi Sankyo INC. | $24.04 | 2019 | |
| Pfizer INC. | $22.07 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $15.74 | 2019 | |
| Cook Medical LLC | $14.67 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.35 | 2019 | |
| Medtronic Vascular, INC. | $11.54 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.14 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.